Evidence map›Paper›PMID 10022818›Full record

ArticleOncogene1999

Differential stability of the DNA-activated protein kinase catalytic subunit mRNA in human glioma cells.

A M Galloway, C A Spencer, C W Anderson, M J Allalunis-Turner

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

A M GallowayExperimental Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada.
C A Spencer
C W Anderson
M J Allalunis-Turner
University of Alberta · CABrookhaven National Laboratory · US

Funding

FUNCTION OF THE HUMAN DNA-ACTIVATED PROTEIN KINASER01GM052825 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI ANDERSON, CARL W · 1996 to 1999
–
NIGMS NIH HHS GM52825
6 · The paper itself

Abstract

DNA-dependent protein kinase (DNA-PK) functions in double-strand break repair and immunoglobulin [V(D)J] recombination. We previously established a radiation-sensitive human cell line, M059J, derived from a malignant glioma, which lacks the catalytic subunit (DNA-PKcs) of the DNA-PK multiprotein complex. Although previous Northern blot analysis failed to detect the DNA-PKcs transcript in these cells, we show here through quantitative studies that the transcript is present, albeit at greatly reduced (approximately 20x) levels. Sequencing revealed no genetic alteration in either the promoter region, the kinase domain, or the 3' untranslated region of the DNA-PKcs gene to account for the reduced transcript levels. Nuclear run-on transcription assays indicated that the rate of DNA-PKcs transcription in M059J and DNA-PKcs proficient cell lines was similar, but the stability of the DNA-PKcs message in the M059J cell line was drastically (approximately 20x) reduced. Furthermore, M059J cells lack an alternately spliced DNA-PKcs transcript that accounts for a minor (5-20%) proportion of the DNA-PKcs message in all other cell lines tested. Thus, alterations in DNA-PKcs mRNA stability and/or the lack of the alternate mRNA may result in the loss of DNA-PKcs activity. This finding has important implications as DNA-PKcs activity is essential to cells repairing damage induced by radiation or radiomimetric agents.

Indexed as

DNA-Binding ProteinsAlternative SplicingCell LineDNA-Activated Protein KinaseFibroblastsGliomaHumansNuclear ProteinsPolymerase Chain ReactionPromoter Regions, GeneticProtein Serine-Threonine KinasesRadiation ToleranceRNA, MessengerRNA, NeoplasmSequence Analysis, DNATranscription, GeneticDNA-Activated Protein KinaseDNA-Binding ProteinsNuclear ProteinsPRKDC protein, humanProtein Serine-Threonine KinasesRNA, MessengerRNA, Neoplasm

Identifiers

PMID10022818
OpenAlexW2315157889

What OpenQuestion holds

Texttitle and abstract
measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.